Skip to search formSkip to main contentSkip to account menu

Foradil

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Background: Co-Suspension™ Delivery Technology offers a novel pharmaceutical platform for inhaled drug therapy. This randomized… 
2006
2006
Formoterol, a long-acting beta (2)-agonist with a rapid onset of bronchodilation, is available in various delivery devices… 
2006
2006
Background: Chronic obstructive pulmonary disease (COPD) management guidelines recommend regular treatment with one or more long… 
2004
2004
Background: For maximum treatment compliance there is a need to provide asthma patients with devices that suit their particular… 
Review
2004
Review
2004
Evaluation of patients with chronic obstructive pulmonary disease (COPD) often includes the use of post‐bronchodilator… 
2003
2003
The objectives of this study were to compare the efficacy and tolerability of twice-daily formoterol dry powder 12 µg and 24 µg… 
2003
2003
Die Standardtherapie des mittelgradigen und schweren Asthma bronchiale besteht aus einer kombinierten antiinflammatorischen… 
2001
2001
This randomised, multicentre, parallel‐group study compared the clinical efficacy and ease of handling of two dry powder inhalers… 
1999
1999
BACKGROUND In many countries, two dry powder formulations of inhaled formoterol are available for clinical use; one uses a single…